US IVF & Fertility Marketing Benchmark 2026

Methodology and data sources

The 2026 US IVF and Fertility Marketing Benchmark aggregates first-party Ichelon Consulting US fertility client marketing data across the January to August 2026 observation window (14 fertility clinics in the client base distributed across mandate and non-mandate states); public search-behavior signals; and third-party Google Ads CPC data. All figures are aggregate — no individual clinic, patient, or engagement-specific data is reported.

Metro selection: the top 15 US fertility metros by fertility-Google-search-volume — New York, Los Angeles, Chicago, San Francisco Bay Area, Boston, Washington DC, Philadelphia, Dallas-Fort Worth, Houston, Miami, Atlanta, Phoenix, Seattle, Portland, Denver — plus Austin, for 16 metros in the table below. Corrected 7 October 2026: an earlier version described the sample as 15 metros while the table listed 16, and marked Philadelphia and Seattle as partial-mandate metros although Pennsylvania and Washington do not have state IVF coverage mandates. Split: mandate-state metros (NY-NYC, IL-Chicago post-Family-Building-Act, CA-SF-Bay-and-LA post-SB-729, MA-Boston, NJ-northern-NJ, CO-Denver post-Building-Families-Act) versus non-mandate-state metros (TX-Dallas-Houston-Austin, FL-Miami, GA-Atlanta, AZ-Phoenix, WA-Seattle, PA-Philadelphia, OR-Portland, DC-DMV partial via federal-employee coverage).

Mandate-state vs non-mandate-state CPC benchmarks

Mandate-state IVF Google Ads CPC averages $9 to $17 per click across the sample; non-mandate-state IVF CPC averages $18 to $34. The gap reflects underlying search-intent differences. In mandate states, the fertility patient arrives at Google already knowing insurance covers the cycle and searches primarily for provider selection ("best IVF clinic in Chicago," "top rated fertility specialist NYC"). In non-mandate states the patient is comparing packages, evaluating cash-pay pricing, and researching financing options, which drives higher competitive bidding on price-and-package-oriented keywords.

Employer-benefit funnel conversion

Employer-benefit third-party administrator acceptance messaging materially lifts conversion in metros with high tech-employer or corporate-HQ density. Practices that build benefit-name-specific landing pages (for example, "[benefit administrator] in-network fertility clinic in Austin") and surface acceptance in the six-placement empanelment-surfacing framework capture 28 to 46 percent higher conversion in high-tech-employer metros compared to practices that surface only generic in-network status.

Lift is highest in Puget Sound, the San Francisco Bay Area and Austin (large technology-employer bases), Manhattan (finance-industry employers) and Boston (biotech employers), where employer fertility benefits cover a meaningful share of patients. Lower-tech-employer metros (San Antonio, Charlotte, Nashville, Portland) still see positive lift but at 12 to 22 percent range.

LGBTQ+ family-building funnel performance

LGBTQ+ family-building funnels in metros with high LGBTQ+ population share (Portland, San Francisco Bay Area, Manhattan, Miami Beach, Washington DC, Chicago) run 12 to 22 percent of total fertility funnel volume when marketing is scoped to pathway-specific creative (reciprocal IVF, sperm-donor selection walkthroughs, gestational surrogacy explainers, trans and non-binary fertility preservation). Metros without LGBTQ+-specific funnel design typically capture 4 to 8 percent of the same population share — meaning meaningful addressable market is forfeited by generic family-building creative.

Portland leads the sample at 22 percent LGBTQ+ funnel share (reflecting the highest US metro LGBTQ+ population share). San Francisco Bay Area, Manhattan, and Miami Beach follow at 16 to 20 percent. DC, Chicago, and Boston sit at 12 to 16 percent. Non-coastal-metro clinics under-invest in this funnel meaningfully — Denver, Atlanta, Austin, and Seattle all carry LGBTQ+ addressable market larger than typical clinic marketing captures.

Donor and surrogate pathway conversion benchmarks

Donor-egg pathway funnel conversion (initial consultation booking to donor-cycle commitment) runs 6 to 14 percent depending on state, pricing transparency, and donor-database access quality. Donor-sperm funnel conversion runs higher (10 to 20 percent) reflecting lower financial commitment per cycle. Embryo-donation funnel is smaller volume but higher conversion (12 to 18 percent) reflecting the specific patient population that seeks that pathway.

Gestational surrogacy funnel conversion is dominated by state legal-landscape variance. Surrogacy-friendly states with codified pre-birth-order pathways (California, Illinois, Washington, Colorado, Nevada, Florida, Texas with procedural constraints) see meaningful surrogacy funnel volume; surrogacy-restrictive states (Michigan, Louisiana, historically Nebraska) see minimal. Cross-state surrogacy — intended parents in a restrictive state pursuing surrogacy with a gestational carrier in a permissive state — accounts for a growing share of the surrogacy funnel and shifts marketing to a cross-state framing.

Single vs multi-cycle package share benchmarks

Single-cycle package selection dominates the mandate-state fertility funnel (approximately 70 to 82 percent of covered-patient package selection in the sample) because coverage typically pays per-cycle up to a state-defined maximum. Multi-cycle package selection dominates the non-mandate cash-pay funnel (approximately 55 to 68 percent of cash-pay package selection) because the shared-risk-or-refund framing meaningfully changes the buyer's mental model — from "can I afford one cycle" to "what happens if it takes more than one."

Fertility preservation (elective egg-freezing) funnel benchmarks

Elective egg-freezing (fertility preservation for social or medical reasons) has continued to grow as a cash-pay funnel share of total fertility marketing volume. Employer-benefit coverage of elective egg-freezing has expanded meaningfully through employer fertility-benefit programs, which shifts elective preservation from pure-cash-pay to hybrid-covered-plus-cash-pay in the tech-employer covered-lives base. Marketing implication: elective egg-freezing funnels should surface employer-benefit acceptance alongside patient-financing options, and the funnel design differs materially for the covered patient versus the pure-cash-pay patient.

SB 729 California, IL Family Building Act, FEHB IVF expansion — impact modeling

Three recent mandate expansions materially reshape 2026 and 2027 fertility marketing dynamics.

California SB 729 (2024 mandate expansion): Expands commercial insurance coverage for fertility diagnosis and treatment including IVF for fully insured large-group health plans (employers with 100 or more employees; self-funded plans are not covered). It was signed in September 2024 and originally applied to policies issued, amended or renewed from 1 July 2025; implementation was delayed to 1 January 2026, so most calendar-year plans pick it up from their 2026 plan year. Ichelon Consulting US's impact modeling suggests California CAC will move materially lower over the 24 months following full implementation as the newly-covered patient population enters the funnel with mandate-state search-intent patterns rather than cash-pay-shopping patterns. CPC will move lower on cash-pay-oriented keywords and higher on provider-selection keywords.

Illinois Family Building Act (2023 mandate expansion): Expanded IL fertility coverage requirements. The 2023-through-2026 window has been the transition period as covered-patient populations activate benefits and enter the fertility funnel. IL CAC has already moved materially lower in the sample compared to pre-2023 baseline.

FEHB IVF expansion (2024): The Federal Employees Health Benefits program expanded IVF coverage for eligible federal employees. Impact is concentrated in DC-DMV, Maryland-Virginia, and metros with substantial federal-employee populations. Practices serving these metros should audit FEHB acceptance surfacing and build federal-employee-scoped landing content.

Multilingual creative lift benchmarks

Spanish-paired creative improves acquisition efficiency (lowers CAC) in Latinx-heavy metros, with Miami (Spanish-first market) showing the largest improvement. Corrected 7 October 2026: an earlier version said Spanish creative "lifts CAC" by a stated percentage, which read as a cost increase; the percentage has been removed because its exact basis could not be confirmed. Portuguese creative in Miami-Aventura and Boston-Cambridge Brazilian-American concentrations delivers meaningful lift. Mandarin and Cantonese creative in Bay Area, Los Angeles, Seattle Eastside, and Queens NY delivers lift. Practices marketing to these catchments in English only forfeit some of that conversion.

2026 forecast and strategic recommendations

The 2026 US fertility market is characterized by expanding mandate coverage (California SB 729, IL Family Building Act, potential 2027 state-level expansions in additional states), growing employer-benefit third-party administrator adoption particularly in tech and biotech, continued LGBTQ+ funnel share growth as generational demographic shift continues, elective egg-freezing category growth (both cash-pay and employer-covered), and AI-search-driven marketing changes as AI Overview citations become meaningful for fertility-condition and fertility-package queries. Practices that invest in employer-benefit landing families, LGBTQ+ pathway-specific creative, donor and surrogate pathway content depth, and multilingual creative for demographic-appropriate catchments will be positioned for the 2027 competitive landscape.

Related reports and playbooks